GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
Background: The duration of protection after hepatitis B vaccination of infants is unknown. Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 ...
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they opt out at 90 hospitals.
Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...
Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths increased from 1.1 million in 2019 to 1.3 million in 2022, rates now similar ...
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...
Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...
These immune cells are our first line of defence ... control groups of patients with chronic hepatitis C and chronic hepatitis B. ‘The lack of TIGIT activity on certain NK cells is apparently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback